The Food And Drug Administration (FDA) announced on Wednesday, January 26, 2011 a link between breast implants and cancer. The FDA has launched an investigation into sourcing the relationship between anaplastic large cell lymphoma (ALCL), a rare form of cancer, and breast implants following the diagnoses of 60 cases ALCL in women with saline or silicon implants.
The FDA is monitoring the possible link and has required plastic surgeons to report cases of ALCL in women with implants. The FDA is also seeking to determine how implants trigger lymphoma and the best treatment options for this form of cancer. The FDA advises women who have problems associated with their implants, including pain, lumps, swelling, or asymmetry, are advised to seek medical treatment.
An estimated 10 million women worldwide have breast implants.